nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti–Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
|
Lee, David |
|
2004 |
4 |
3 |
p. 159-162 4 p. |
artikel |
2 |
Current Status of Clinical Studies for Colorectal Cancer in Taiwan
|
Chen, Li-Tzong |
|
2004 |
4 |
3 |
p. 196-203 8 p. |
artikel |
3 |
Dihydopyrimidine Dehydrogenase: A Critical Molecular Biomarker for 5-Fluorouracil Toxicity
|
Chu, Edward |
|
2004 |
4 |
3 |
p. 150- 1 p. |
artikel |
4 |
Dihydropyrimidine Dehydrogenase Deficiency, a Pharmacogenetic Syndrome Associated with Potentially Life-Threatening Toxicity Following 5-Fluorouracil Administration
|
Ezzeldin, Hany |
|
2004 |
4 |
3 |
p. 181-189 9 p. |
artikel |
5 |
Highlights From: 40th Annual Meeting of the American Society of Clinical Oncology; New Orleans, LA June 2004
|
Lee, David |
|
2004 |
4 |
3 |
p. 154-158 5 p. |
artikel |
6 |
Roles of Infusional High-Dose 5-Fluorouracil with Leucovorin in Advanced Colorectal Cancer
|
Liu, Jin-Hwang |
|
2004 |
4 |
3 |
p. 204-205 2 p. |
artikel |
7 |
The Role of Pemetrexed in the Treatment of Gastrointestinal Malignancy
|
Hochster, Howard S. |
|
2004 |
4 |
3 |
p. 190-195 6 p. |
artikel |
8 |
Topoisomerase I Inhibitors in the Treatment of Gastrointestinal Cancer: From Intravenous to Oral Administration
|
Kuppens, Isa E.L.M. |
|
2004 |
4 |
3 |
p. 163-180 18 p. |
artikel |